
Dermalife Pharmaceuticals Private Limited
About Dermalife Pharmaceuticals Private Limited
Data last updated:
Dermalife Pharmaceuticals Private Limited is a private limited company based in Allahabad, Uttar Pradesh, India. It operates in the social work activities with accommodation segment of the non-profit sector. It was incorporated on 19 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85310UP2017PTC089330.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nasim Ahmad Ansari and Jamshed Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 17/22 A Beniganj, Allahabad, Uttar Pradesh, India – 211016.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Dermalife Pharmaceuticals Private Limited's registered office is in Allahabad, Uttar Pradesh.
- Registered Address17/22 A Beniganj, Allahabad, Uttar Pradesh, India – 211016
- IndustryNon-Profit Organizations, Social Work Activities With Accommodation, Social Work
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Dermalife Pharmaceuticals Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Dermalife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Dermalife Pharmaceuticals Private Limited
Dermalife Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nasim Ahmad Ansari | Director | 19 Jan 2017 | 9 Years 9 Months | Current |
| Jamshed Ahmad | Director | 19 Jan 2017 | 9 Years 9 Months | Current |
| Avinash Kumar Srivastava | Director | 19 Jan 2017 | 9 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Dermalife Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dermalife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Dermalife Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Dermalife Pharmaceuticals Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Avinash Kumar Srivastava was appointed as Director on 19 Jan 2017.
Frequently asked questions
Dermalife Pharmaceuticals is an active private limited company based in Allahabad, Uttar Pradesh, India. The company works in social work activities with accommodation, within the non-profit organizations industry. It was incorporated on 19 January 2017 (9+ years old) and is registered under CIN U85310UP2017PTC089330.
Dermalife Pharmaceuticals has 3 current directors:
- Nasim Ahmad Ansari - Director
- Jamshed Ahmad - Director
- Avinash Kumar Srivastava - Director
The latest financial statements of Dermalife Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Dermalife Pharmaceuticals is U85310UP2017PTC089330. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dermalife Pharmaceuticals was incorporated on 19 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Avinash Kumar Srivastava was appointed as Director on 19 Jan 2017. Jamshed Ahmad was appointed as Director on 19 Jan 2017. Nasim Ahmad Ansari was appointed as Director on 19 Jan 2017.
The registered office of Dermalife Pharmaceuticals is at 1722 A Beniganj, Allahabad, Uttar Pradesh, India – 211016.
Dermalife Pharmaceuticals operates in the non-profit organizations industry, in the social work activities with accommodation segment.
The compliance status of Dermalife Pharmaceuticals is compliant as of 04 August 2026. The company is actively filing with the Registrar of Companies.
Dermalife Pharmaceuticals can be reached at its registered office: 1722 A Beniganj, Allahabad, Uttar Pradesh, India – 211016.